What Researchers Did
Researchers presented a case report detailing the successful management of a 64-year-old woman with stage 0 medication-related osteonecrosis of the jaw (MRONJ) using amoxicillin/clavulanate and hyperbaric oxygen therapy.
What They Found
They found that a 64-year-old woman with stage 0 MRONJ, previously refractory to clindamycin and local debridement, was successfully treated with a combination of amoxicillin/clavulanate and hyperbaric oxygen therapy. This case suggests that hyperbaric oxygen therapy, alongside antibiotics, may be an effective management strategy for this specific condition.
What This Means for Canadian Patients
For Canadian patients diagnosed with stage 0 medication-related osteonecrosis of the jaw, this case report suggests that hyperbaric oxygen therapy combined with antibiotics could be a potential treatment option, especially if other therapies have failed. Patients should discuss this approach with their healthcare providers to determine if it is suitable for their individual circumstances.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The primary limitation of this study is its nature as a single case report, which limits the generalizability of its findings to a broader patient population.